Overview
Ectopic aldosterone-producing tumor is an extremely rare cause of primary hyperaldosteronism (also known as Conn syndrome when caused by adrenal adenomas) in which aldosterone is secreted by a tumor located outside the adrenal glands. Unlike the typical forms of primary hyperaldosteronism caused by adrenal adenomas or bilateral adrenal hyperplasia, these tumors arise in ectopic locations, most commonly in the ovaries, kidneys, or other extra-adrenal sites. The excess aldosterone production leads to the same clinical consequences as adrenal-based hyperaldosteronism, primarily affecting the cardiovascular and renal systems. Key clinical features include resistant hypertension (high blood pressure that is difficult to control with standard medications), hypokalemia (low potassium levels in the blood), metabolic alkalosis, muscle weakness, fatigue, and in some cases cardiac arrhythmias related to electrolyte imbalances. Patients may also experience polyuria (excessive urination) and polydipsia (excessive thirst) due to the effects of hypokalemia on kidney function. The diagnosis can be particularly challenging because standard imaging of the adrenal glands may appear normal, and adrenal vein sampling — the gold standard for lateralizing aldosterone production in typical primary hyperaldosteronism — may yield confusing results. Treatment primarily involves surgical resection of the ectopic aldosterone-producing tumor when it can be identified and localized. Advanced imaging techniques, including CT scanning, MRI, and in some cases functional imaging, are essential for tumor localization. Prior to surgery or in cases where surgery is not feasible, medical management with mineralocorticoid receptor antagonists such as spironolactone or eplerenone can help control blood pressure and correct hypokalemia. The prognosis is generally favorable when the tumor is successfully identified and completely removed, often resulting in resolution or significant improvement of hypertension and electrolyte abnormalities.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Ectopic aldosterone-producing tumor.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Ectopic aldosterone-producing tumor at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Ectopic aldosterone-producing tumor.
Community
No community posts yet. Be the first to share your experience with Ectopic aldosterone-producing tumor.
Start the conversation →Latest news about Ectopic aldosterone-producing tumor
No recent news articles for Ectopic aldosterone-producing tumor.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Ectopic aldosterone-producing tumor
What is Ectopic aldosterone-producing tumor?
Ectopic aldosterone-producing tumor is an extremely rare cause of primary hyperaldosteronism (also known as Conn syndrome when caused by adrenal adenomas) in which aldosterone is secreted by a tumor located outside the adrenal glands. Unlike the typical forms of primary hyperaldosteronism caused by adrenal adenomas or bilateral adrenal hyperplasia, these tumors arise in ectopic locations, most commonly in the ovaries, kidneys, or other extra-adrenal sites. The excess aldosterone production leads to the same clinical consequences as adrenal-based hyperaldosteronism, primarily affecting the card
How is Ectopic aldosterone-producing tumor inherited?
Ectopic aldosterone-producing tumor follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Ectopic aldosterone-producing tumor typically begin?
Typical onset of Ectopic aldosterone-producing tumor is adult. Age of onset can vary across affected individuals.
Which specialists treat Ectopic aldosterone-producing tumor?
1 specialists and care centers treating Ectopic aldosterone-producing tumor are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.